Updates in the Management of Graft-Versus-Host Disease

Updates in the Management of Graft-Versus-Host Disease

Episodes

Specialty:

All

Year:

All

EP. 1: Timing of Referral for Transplant

ByCorey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute,Joseph H. Antin, MD, Dana-Farber Cancer Institute,Yi-Bin A. Chen, MD, Massachusetts General Hospital,Zachariah M. DeFilipp, MD, Massachusetts General Hospital

June 19th 2020

EP. 2: Members of the Transplant Team

ByCorey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute,Joseph H. Antin, MD, Dana-Farber Cancer Institute,Yi-Bin A. Chen, MD, Massachusetts General Hospital,Zachariah M. DeFilipp, MD, Massachusetts General Hospital

June 19th 2020

EP. 3: Overview of Graft-Vs-Host Disease

ByCorey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute,Joseph H. Antin, MD, Dana-Farber Cancer Institute,Yi-Bin A. Chen, MD, Massachusetts General Hospital,Zachariah M. DeFilipp, MD, Massachusetts General Hospital

June 19th 2020

EP. 4: Risk Factors for Graft-vs-Host Disease

ByCorey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute,Joseph H. Antin, MD, Dana-Farber Cancer Institute,Yi-Bin A. Chen, MD, Massachusetts General Hospital,Zachariah M. DeFilipp, MD, Massachusetts General Hospital

June 19th 2020

EP. 5: Special Transplant Situations

ByCorey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute,Joseph H. Antin, MD, Dana-Farber Cancer Institute,Yi-Bin A. Chen, MD, Massachusetts General Hospital,Zachariah M. DeFilipp, MD, Massachusetts General Hospital

June 19th 2020

EP. 6: Graft-vs-Host Disease Prophylaxis Clinical Trials

ByCorey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute,Joseph H. Antin, MD, Dana-Farber Cancer Institute,Yi-Bin A. Chen, MD, Massachusetts General Hospital,Zachariah M. DeFilipp, MD, Massachusetts General Hospital

June 19th 2020

EP. 7: Shifting Paradigm in Treating Acute Graft-vs-Host Disease

ByCorey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute,Joseph H. Antin, MD, Dana-Farber Cancer Institute,Yi-Bin A. Chen, MD, Massachusetts General Hospital,Zachariah M. DeFilipp, MD, Massachusetts General Hospital

June 19th 2020

EP. 8: Treating Chronic Graft-vs-Host Disease

ByCorey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute,Joseph H. Antin, MD, Dana-Farber Cancer Institute,Yi-Bin A. Chen, MD, Massachusetts General Hospital,Zachariah M. DeFilipp, MD, Massachusetts General Hospital

June 19th 2020

Trending on OncLive

ASCO Issues First Guideline on ctDNA Testing in Solid Tumors and Lymphoma

ASCO Guideline Update Broadens First-Line Treatment Options for HER2+ Gastroesophageal Cancer

Dr Wainberg on INCB161734 Activity in Refractory Pancreatic Cancer

European Commission Approves Teclistamab Plus Daratumumab for R/R Myeloma

FDA Awards Fast Track Designation to Safusidenib in IDH1-Mutant Glioma